Company news
Artivion, Inc. (NYSE:AORT) news
Every Artivion, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
July 23, 2026
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
June 29, 2026
Artivion to Participate in the 2026 Truist Securities MedTech Conference
June 10, 2026
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
May 18, 2026
Artivion Completes Acquisition of Endospan Ltd.
May 18, 2026
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
May 7, 2026
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results
April 23, 2026
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
April 7, 2026
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 3, 2026
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thorac...
February 2, 2026
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
January 29, 2026
Artivion Reports Third Quarter 2025 Financial Results
November 6, 2025
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
November 6, 2025
Artivion to Participate in the Stifel 2025 Healthcare Conference
October 29, 2025
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
October 23, 2025
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Ca...
October 13, 2025
Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
September 5, 2025
Artivion Reports Second Quarter 2025 Financial Results
August 7, 2025
Artivion to Participate in Upcoming Investor Conferences
July 30, 2025
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results
July 24, 2025
Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Com...
May 28, 2025
Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
May 14, 2025
Artivion Reports First Quarter 2025 Financial Results
May 5, 2025
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery...
May 5, 2025
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
April 21, 2025
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 4, 2025
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
February 24, 2025